[go: up one dir, main page]

NO20081037L - Fremgangsmate for oppnaelse av 3,3-difenylpropylaminer - Google Patents

Fremgangsmate for oppnaelse av 3,3-difenylpropylaminer

Info

Publication number
NO20081037L
NO20081037L NO20081037A NO20081037A NO20081037L NO 20081037 L NO20081037 L NO 20081037L NO 20081037 A NO20081037 A NO 20081037A NO 20081037 A NO20081037 A NO 20081037A NO 20081037 L NO20081037 L NO 20081037L
Authority
NO
Norway
Prior art keywords
alkyl
diphenylpropylamines
compounds
obtaining
coor6
Prior art date
Application number
NO20081037A
Other languages
English (en)
Inventor
Antonio Lorente Bonde-Larsen
Pablo Martin Pascual
Jorge Martin Juarez
Miquel Armengol Montserrat
Original Assignee
Interquim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interquim Sa filed Critical Interquim Sa
Publication of NO20081037L publication Critical patent/NO20081037L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/28—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Oppfinnelsen angår en fremgangsmåte for fremstilling av 3,3-difenylpropylaminer (I), hvori R1 er H, alkyl, haloalkyl eller alkoksyalkyl, R2 er alkyl, alkoksy, halogen, NO2, CN, CHO, som kan være fri eller beskyttet, CH2OH eller COOR6, og R3 og R4 er uavhengig valgt fra H og alkyl eller sammen med nitrogenet til hvilket de er bundet danner en ring som har 3 til 7 ledd. Fremgangsmåten ifølge oppfinnelsen består i å omsette et propylenfenylamin og et disubstituert aromatisk hydrokarbon og, hvis nødvendig, separere den ønskede enantiomer eller blandingen av enantiomerer, og/eller omdanne forbindelsen (I) til et salt. Forbindelser (I) er muskarinreseptorantagonister som kan anvendes ved behandling av urininkontinens og andre symptomer på urinblærehyperaktivitet. Nevnte forbindelser inkluderer tolterodin.
NO20081037A 2005-08-05 2008-02-27 Fremgangsmate for oppnaelse av 3,3-difenylpropylaminer NO20081037L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200501990A ES2268987B1 (es) 2005-08-05 2005-08-05 Procedimiento para la obtencion de 3,3-difenilpropilaminas.
PCT/ES2006/000458 WO2007017544A2 (es) 2005-08-05 2006-08-03 Procedimiento para la obtención de 3,3-difenilpropilaminas

Publications (1)

Publication Number Publication Date
NO20081037L true NO20081037L (no) 2008-04-23

Family

ID=37727675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081037A NO20081037L (no) 2005-08-05 2008-02-27 Fremgangsmate for oppnaelse av 3,3-difenylpropylaminer

Country Status (11)

Country Link
US (2) US8039672B2 (no)
EP (1) EP1927585B1 (no)
JP (1) JP2009503035A (no)
KR (1) KR20080043811A (no)
CN (1) CN101277926A (no)
AU (1) AU2006277906A1 (no)
BR (1) BRPI0614387A2 (no)
CA (1) CA2618446A1 (no)
ES (2) ES2268987B1 (no)
NO (1) NO20081037L (no)
WO (1) WO2007017544A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20050249A1 (it) * 2005-02-18 2006-08-19 Dipharma Spa Procedimento per la preparazione di tolterodina
WO2007147547A1 (en) * 2006-06-20 2007-12-27 Lek Pharmaceuticals D.D. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines
EP2281801B1 (en) 2009-07-27 2014-01-08 Crystal Pharma, S.A.U. Process for obtaining 3,3-diphenylpropylamines
IT1396373B1 (it) 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
IT1397521B1 (it) 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
EP2364966A1 (en) 2010-03-09 2011-09-14 LEK Pharmaceuticals d.d. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
CN103044273B (zh) * 2012-11-29 2014-12-24 珠海保税区丽珠合成制药有限公司 一种酒石酸托特罗定的合成方法
CN103044274B (zh) * 2012-11-29 2014-10-22 珠海保税区丽珠合成制药有限公司 一种无溶剂合成酒石酸托特罗定的方法
CN111470971B (zh) * 2020-05-09 2023-06-16 浙江大学衢州研究院 防止二异丙基乙胺生产中催化剂ZnCl2结块的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239908A (en) * 1979-12-10 1980-12-16 G.D. Searle & Co. N-aralkenyl-N'-cyano-N"-(heterocyclylthioalkyl)-guanidines
US5382600A (en) 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
AU728395B2 (en) 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
DE19722373A1 (de) * 1997-05-28 1998-12-03 Hoechst Ag Verwendung eines Rhodiumkatalysators sowie ein neues Verfahren zur Herstellung von 2-arylsubstituierten Ethylen- und Ethylaminen
SE9904850D0 (sv) 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
PE20020547A1 (es) 2000-10-24 2002-06-12 Upjohn Co Uso de la tolterodina en tratamientos del asma
IN191835B (no) 2001-08-03 2004-01-10 Ranbaxy Lab Ltd
ES2235648B1 (es) 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
WO2007147547A1 (en) * 2006-06-20 2007-12-27 Lek Pharmaceuticals D.D. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines

Also Published As

Publication number Publication date
EP1927585B1 (en) 2016-07-27
EP1927585A4 (en) 2010-08-18
CA2618446A1 (en) 2007-02-15
KR20080043811A (ko) 2008-05-19
BRPI0614387A2 (pt) 2011-03-22
US8039672B2 (en) 2011-10-18
EP1927585A2 (en) 2008-06-04
WO2007017544A3 (es) 2007-04-19
ES2592885T3 (es) 2016-12-02
AU2006277906A1 (en) 2007-02-15
ES2268987B1 (es) 2008-02-01
US20110319666A1 (en) 2011-12-29
CN101277926A (zh) 2008-10-01
US20100286446A1 (en) 2010-11-11
JP2009503035A (ja) 2009-01-29
ES2268987A1 (es) 2007-03-16
WO2007017544A2 (es) 2007-02-15

Similar Documents

Publication Publication Date Title
NO20081037L (no) Fremgangsmate for oppnaelse av 3,3-difenylpropylaminer
ATE515505T1 (de) Heterocyclische fxr-bindende verbindungen
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
NO20053960L (no) Piperidin-benzensulfonamidderivater
ATE555105T1 (de) Heterocyclische fxr-bindende verbindungen
PE20091100A1 (es) Nuevos compuestos 010
WO2010088455A3 (en) Cromolyn derivatives and related methods of imaging and treatment
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
RU2003105900A (ru) Производные 4,5-дигидро-1h-пиразола, обладающие cb1-антагонистической активностью
NO20083197L (no) Substituert cinnolin-derivater som GABAA-reseptor modulatorer og metode for deres syntese
NO20064579L (no) Bifenylforbindelser anvendelige som muskariniske receptorantagonister
NO20074057L (no) 2,4-Diaminopyridopyrimidinderivater og deres anvendelse som mTOR-inhibitorer
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20081476L (no) Substituerte benzimidazoler og fremgangsmater for fremstilling
RU2017114960A (ru) СПОСОБЫ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ В ПОЛУЧЕНИИ C5aR АНТАГОНИСТОВ
NO20073208L (no) 4-fenylsubstituerte tetrahydrotsokindiner og anvendelse derav til a blokkere gjenopptak av norepinefrin, dopamin og serotonin
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
AR078321A1 (es) Derivados de 2,4'-bipiridina como inhibidores de cinasa (cdk9)
AR040489A1 (es) Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen
WO2008035212A3 (en) Processes for preparing intermediate compounds useful for the preparation of cinacalcet
NO20064892L (no) Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av
WO2007054444A3 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
MX2007004230A (es) Compuestos de tienopiridinona y metodos de tratamiento.
TW200714587A (en) Biphenyl compounds useful as muscarinic receptor antagonists
DE602006010540D1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application